Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access

NCT04489849 is registered in ClinicalTrials.gov with National Taiwan University Hospital Hsin-Chu Branch as lead sponsor.

NCT NCT04489849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04489849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access
Lead sponsor
National Taiwan University Hospital Hsin-Chu Branch
Phase
Phase 4
Overall status
Unknown status
Start date
March 14, 2020
Completion date
June 14, 2022
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis access failure